A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease

The yellow fever virus (YFV) vaccine 17D-204 is considered safe and effective, yet rare severe adverse events (SAEs), some resulting in death, have been documented following vaccination. Individuals exhibiting post-vaccinal SAEs are ideal candidates for antiviral monoclonal antibody (MAb) therapy; t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antiviral Res
Main Authors: Calvert, Amanda E., Dixon, Kandice L., Piper, Joseph, Bennett, Susan L., Thibodeaux, Brett A., Barrett, Alan D.T., Roehrig, John T., Blair, Carol D.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899248/
https://ncbi.nlm.nih.gov/pubmed/27126613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2016.04.013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados